## **Core Concept**
The question assesses knowledge of ovarian reserve markers, specifically in the context of a premenopausal female. Ovarian reserve refers to the quantity and quality of a woman's remaining oocytes. **Anti-Müllerian hormone (AMH)** is a key marker used to evaluate ovarian reserve.

## **Why the Correct Answer is Right**
AMH, or **Anti-Müllerian hormone**, is produced by the granulosa cells of small antral follicles in the ovaries and reflects the number of remaining follicles, hence serving as a marker of ovarian reserve. Levels of AMH are known to decrease with age and are also low in women with diminished ovarian reserve. It is considered a reliable marker for assessing ovarian reserve.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While certain genetic markers and hormonal levels can provide insights into ovarian function, they are not as directly correlated with ovarian reserve as AMH.
- **Option B:** This option might refer to another hormone or marker, but without specificity, it's hard to address directly. However, it's known that AMH is more specific for ovarian reserve than many other hormonal markers.
- **Option C:** This could potentially refer to another marker or test, but again, specificity to ovarian reserve is key, and AMH holds that role.
- **Option D:** Similarly, without specificity, it's challenging to directly refute, but AMH's role in assessing ovarian reserve is well-established.

## **Clinical Pearl / High-Yield Fact**
A critical point to remember is that **AMH levels are used not only to assess ovarian reserve but also to guide decisions regarding fertility treatments**. Low AMH levels may indicate a reduced ovarian reserve, suggesting a potentially poorer response to ovarian stimulation during fertility treatments.

## **Correct Answer:** . AMH (Anti-Müllerian Hormone)